For laboratory and research use only. Not for human consumption.

Thanksgiving: Buy 2, get the 3rd freeAny product, same compound, 3 in the cart. No code needed. Ends Wednesday, October 14.Shop the catalog
Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|
Regulatory

Peptide Purity Standards: >99% HPLC Testing Explained

All peptide batches undergo independent testing to confirm >99% purity via HPLC and mass spectrometry before shipment. Third-party labs handle every analysis to ensure unbiased results, with failing batches rejected entirely. This process matches pharmaceutical standards used in clinical trials, providing verified quality for research compounds like BPC-157, GHK-Cu, and TB-500.

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Reviewed by Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Written by Volta Peptides Editorial Team · Reviewed September 15, 2026

May 12, 2026Updated June 19, 20263 min read

Key Takeaways

  • •>99% target peptide by molecular fraction
  • •Mass spectrometry identity confirmation
  • •Per-product, per-batch purity data publication
  • •Rejection of failing batches
  • •BPC-157: >99% purity. Check the BPC-157 Research Guide for details.

Every Batch Meets >99% Purity Before Shipment

Independent testing verifies each peptide batch at >99% purity using HPLC analysis. Mass spectrometry confirms the compound's identity. All batches receive 100% testing at third-party labs only.

This multi-layer approach guarantees that researchers receive compounds meeting strict standards. Purity data appears on individual product pages for transparency.

Three Layers of Quality Verification

High-Performance Liquid Chromatography (HPLC) separates molecular components in each batch. It measures the precise percentage of the target peptide, requiring >99% for approval.

Mass spectrometry checks molecular identity. It compares the measured molecular weight to the theoretical value, ensuring the compound matches its description.

Independent third-party analytical laboratories conduct all tests. This setup avoids conflicts of interest, as in-house testing could undermine claims.

Step-by-Step Testing Process

Peptides start with solid-phase peptide synthesis (SPPS), followed by lyophilization into stable powder for storage.

A sample from each production batch undergoes extraction for analysis. Testing occurs batch-by-batch, not through spot-checks or categories.

Samples go to independent labs for HPLC purity checks and mass spectrometry confirmation. The supplier has no role in running or reviewing results.

Batches passing >99% HPLC purity and identity verification get released. Those below the threshold face rejection, with data published on product pages.

Meaning of >99% HPLC Purity

A >99% result indicates that at least 99 out of every 100 parts in the vial is the target peptide. The remaining 1% or less includes synthesis byproducts, truncated sequences, residual solvents, or impurities.

Pharmaceutical-grade material for clinical work is held to the top of the purity range. Volta’s >99% minimum applies that same benchmark to every research batch.

Key aspects include:

  • >99% target peptide by molecular fraction
  • Mass spectrometry identity confirmation
  • Per-product, per-batch purity data publication
  • Rejection of failing batches
In Stock

MOTS-C 10mg

Batch purity 99.4%
In Stock

Retatrutide 10mg

In Stock

Retatrutide 20mg

Batch purity 99.7%

Examples of Verified Compounds

Purity testing covers all catalog items. Examples include:

  • BPC-157: >99% purity. Check the BPC-157 Research Guide for details.
  • GHK-Cu: >99% purity
  • TB-500: >99% purity. See the TB-500 Research Guide.
  • NAD+ 750mg: >99% purity
  • MOTS-C: >99% purity
  • Semax: >99% purity
  • Pinealon: >99% purity
  • CJC-1295/Ipa: >99% purity

Use our Purity Analyzer tool to assess batch quality.


Looking for high-purity research peptides? Browse our catalog for HPLC-verified compounds.

CompoundPuritySizePrice
BPC-157 5mg>99%5mg$34.00
TB-500 5mg>99%5mg$29.00
CJC-1295 No DAC + Ipamorelin 10mg (5+5)>99%10mg$49.00
BPC-157 10mg>99%10mg$44.00

Browse Full Catalog →

Frequently Asked Questions

What purity level do products achieve? All meet >99% via HPLC testing at independent third-party labs.

Who performs the testing? Independent analytical labs handle purity and identity checks. No in-house testing occurs to maintain objectivity.

Where is purity data located? It appears on individual product pages in the catalog. Raw COA documents stay private, but verified data reflects batch standards.

What happens to failing batches? They get rejected and never sell. Only those passing both HPLC and mass spectrometry proceed.

How do HPLC and mass spectrometry differ? HPLC measures purity percentage of the target compound. Mass spectrometry verifies identity by molecular weight match. Both tests are essential.

Key Takeaways on Peptide Quality

Rigorous >99% purity standards ensure reliable research materials. Third-party verification and full batch testing set a high bar matching clinical requirements.

Explore our Free peptide tools like the Peptide Glossary for more insights. Browse the catalog to view purity data.

Research Use Only. This article is provided for informational and educational purposes only. The compounds and topics discussed are intended solely for laboratory and scientific research. This content does not constitute medical advice, and Volta Peptides does not endorse or promote human consumption of any research compound.

About the reviewer

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.

Marcus reviewed this article for scientific and analytical accuracy on September 15, 2026. He did not write it. Technical review is internal review and is not peer review, independent third-party review or medical review.

Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.

Shop Research Peptides

In Stock

MOTS-C 10mg

Batch purity 99.4%
In Stock

Retatrutide 10mg

In Stock

Retatrutide 20mg

Batch purity 99.7%
In Stock

Semaglutide 10mg

In Stock

Semaglutide 20mg

In Stock

Sermorelin 10mg

In Stock

SS-31 10mg

10mg

Batch purity 99.6%
In Stock

TB-500 10mg

10mg

Batch purity 99.5%
In Stock

Tesamorelin 10mg

Batch purity 99.5%

Peptide Tools

Your Cart

Your cart is empty

Browse our catalog to add research compounds.